Video

Episode 16 - MRI Scans and MS

During this segment, the panelists discuss the increased utilization of magnetic resonance imaging (MRI) scans and its impact in multiple sclerosis (MS).

Moderator Fred Lublin, MD, explains the relationship between MRI scans and radiologically isolated syndrome (RIS).

Although beneficial, Gary M. Owens, MD, explains that even in instances where MRI scans suggest MS, not all patients require treatment.

As explained by Dr Lublin, patient accessibility and affordability is also a challenge. Therefore, the panelists explain how radiology programs manage pre-approval processes for MRI scans.

Dr Owens concludes this segment by explaining that while many plans make it simple for patients with, or suspected of, MS to have access to MRI scans, a “broad net” is a consequence.During this segment, the panelists discuss the increased utilization of magnetic resonance imaging scans and its impact in multiple sclerosis.


Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Cathy Eng, MD, FACP, FASCO
Leigh Maria Ramos-Platt, MD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo